Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Levosimendan or Placebo on Exercise Capacity and Hemodynamics in Patients With Advanced Chronic Heart Failure (LOCO-CHF Trial)

NCT03576677 is registered in ClinicalTrials.gov with Finn Gustafsson as lead sponsor.

NCT NCT03576677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03576677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Levosimendan or Placebo on Exercise Capacity and Hemodynamics in Patients With Advanced Chronic Heart Failure (LOCO-CHF Trial)
Lead sponsor
Finn Gustafsson
Phase
Phase 4
Overall status
Unknown status
Start date
August 1, 2019
Completion date
July 30, 2020
Enrollment
42 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure